A detailed history of Legato Capital Management LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 24,180 shares of AXGN stock, worth $350,126. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,180
Holding current value
$350,126
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$7.52 - $14.69 $181,833 - $355,204
24,180 New
24,180 $339,000
Q3 2023

Oct 12, 2023

BUY
$4.68 - $9.26 $520,336 - $1.03 Million
111,183 New
111,183 $555,000
Q2 2023

Aug 17, 2023

BUY
$8.5 - $10.38 $263,338 - $321,582
30,981 Added 36.27%
116,402 $1.06 Million
Q4 2022

Feb 01, 2023

BUY
$9.44 - $13.09 $806,374 - $1.12 Million
85,421 New
85,421 $852,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $612M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.